Thymoglobulin (Genzyme Corporation)
Welcome to the PulseAid listing for the Thymoglobulin drug offered from Genzyme Corporation. This Immunoglobulin G [EPC],Lymphocyte Function Alteration [PE],Increased T Lymphocyte Destruction [PE],Antibody-Surface Protein Interactions [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genzyme Corporation |
| NON-PROPRIETARY NAME: | Anti-thymocyte Globulin (Rabbit) |
| SUBSTANCE NAME: | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Immunoglobulin G [EPC],Lymphocyte Function Alteration [PE],Increased T Lymphocyte Destruction [PE],Antibody-Surface Protein Interactions [MoA],Immunoglobulins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1998-12-30 |
| END MARKETING DATE: | 0000-00-00 |
Thymoglobulin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Thymoglobulin from Genzyme Corporation |
| LABELER NAME: | Genzyme Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 1998-12-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58468-0080_78c993d4-775d-49bb-ada0-d300078398a2 |
| PRODUCT NDC: | 58468-0080 |
| APPLICATION NUMBER: | BLA103869 |
Other LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:
